Uncategorized

Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data

Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data

Published

on

💸 A Series A extension: US-China biotech Degron Therapeutics has collected an additional $40 million for its molecular glue degrader platform. The San Diego and Shanghai biotech has raised $95 million …​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version